

Analysis of the incidence of myasthenia gravis in the Republic of Bashkortostan during 2013–2022
https://doi.org/10.30629/2658-7947-2025-30-4-18-21
Abstract
The aim of the study was to analyze the dynamics of the incidence and prevalence of myasthenia gravis in the Republic of Bashkortostan over the period 2003–2022.
Results. During the analyzed period, the prevalence of myasthenia gravis in the Republic of Bashkortostan was approximately 13 cases per 100,000 population. It was relatively stable over time, except for the group of patients over 60 years of age, which demonstrated a nearly 2-fold increase. The incidence rate showed signifi cant fl uctuations, with an average of 1.4 cases per 100,000 population.
Conclusion. Over the period 2013–2022, there was an increase in the prevalence of myasthenia, which is likely due to an aging population and an increased detection rate. The incidence was subject to signifi cant fl uctuations, which were largely related to organizational factors.
About the Authors
A. V. BergRussian Federation
Ufa, Russia
M. A. Kutlubaev
Russian Federation
Ufa, Russia
References
1. Dresser L, Wlodarski R, Rezania K, Soliven B. Myasthenia Gravis: Epidemiology, Pathophysiology and Clinical Manifestations. J Clin Med. 2021 May 21;10(11):2235. doi: 10.3390/jcm10112235
2. Alekseeva T.M., Kryuchkova V.V., Stuchevskaya T.R., Khalmurzina A.N. Epidemiologic studies of myasthenia gravis: literature review. Neuromuscular Diseases. 2018;8(3):12–18. (In Russ.). https://doi.org/10.17650/2222-8721-2018-8-3-12-18
3. Ishmukhametova A.T., Musin R.G., Khidiyatova I.M., Magzhanov R.V. Epidemiological Studies of Gravis Myasthenia in the Republic of Bashkortostan. Neurological Journal. 2006;(11):16–21. (In Russ.).
4. Kotov SV, Neretin VIa, Agafonov BV, Sidorova OP. Populationbased study of myasthenia in Moscow region. S.S. Korsakov Journal of Neurology and Psychiatry. 2006;106(5):52–5. (In Russ.).
5. Luneva EA, Lunev KV, Smagina IV. Clinical and epidemiological characteristics of myasthenia in the Altai region. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;124(11):198–20. (In Russ.). https://doi.org/10.17116/jnevro2024124111198
6. Romanova T.V. Epidemiological study of myasthenia gravis in the Samara region. Saratov Scientifi c and Medical Journal. 2012;8(1):91–95. (In Russ.).
7. Gasymly E.D., Isaeva N.V., Prokopenko S.V., Andon Yu.N. Epidemiological and clinical characteristics of myasthenia in the Krasnoyarsk region. Neuromuscular Diseases. 2017;7(4):33–38. (In Russ.). https://doi.org/10.17650/2222-8721-2017-7-4-33-38
8. Khatkhe Yu.A., Zabolotskikh N.V., Terpelets S.A. Epidemiologic and populational aspects of myasthenia gravis in the Krasnodar Region. Neuromuscular Diseases. 2018;8(1):28–33. (In Russ.). https://doi.org/10.17650/2222-8721-2018-8-1-28-33
9. Khatke Yu.A., Zabolotskikh N.V., Ivanisova A.V., Petropavlovskaya T.A., Gerasimenko G.A. Epidemiological features of myasthenia gravis. Kuban Scientifi c Medical Bulletin. 2018;25(1):195–198. (In Russ.). https://doi.org/10.25207/1608-6228-2018-25-1-195-198
10. Sciancalepore F, Lombardi N, Valdiserra G, Bonaso M, Cappello E, Hyeraci G, Crescioli G, Celani MG, Cantisani TA, Brunori P, Vecchi S, Bacigalupo I, Locuratolo N, Lacorte E,
11. Vanacore N, Kirchmayer U. Prevalence, Incidence, and Mortality of Myasthenia Gravis and Myasthenic Syndromes: A Systematic Review. Neuroepidemiology. 2024;9:1–14. https://doi.org/10.1159/000539577
12. Dalakas MC, Alexopoulos H, Spaeth PJ. Complement in neurological disorders and emerging complement-targeted therapeutics. Nat Rev Neurol. 2020 Nov;16(11):601–617. https://doi.org/10.1038/s41582-020-0400-0
13. Ye Y, Murdock DJ, Chen C, Liedtke W, Knox CA. Epidemiology of myasthenia gravis in the United States. Front Neurol. 2024;15:1339167. https://doi.org/10.3389/fneur.2024.1339167
Review
For citations:
Berg A.V., Kutlubaev M.A. Analysis of the incidence of myasthenia gravis in the Republic of Bashkortostan during 2013–2022. Russian neurological journal. 2025;30(4):18-21. (In Russ.) https://doi.org/10.30629/2658-7947-2025-30-4-18-21